Development of unmodified NKTs and engineered NKTs for cancer immunotherapy. Unmodified and engineered NKTs are being tested in preclinical models and at the indicated clinical trial stages in patients with cancer with safety and clinical responses reported when applicable. BCM, Baylor College of medicine; HSC, hematopoietic stem cell transplants; iPSC, induced pluripotent stem cell.